Close Menu

Precision Medicine Initiative

The Geisinger National Precision Health Initiative ended in 2019 but its leaders joined Genome Medical to bring genomics-informed care to other health systems.

The center is responsible for developing and maintaining the technical platforms by which people participate in and engage with the program.

The bill would provide additional funding to each NIH institute and center, and would follow a 5.4 percent budget increase received in fiscal 2019.

The All of Us program aims to enroll 1 million Americans willing to donate biological samples and share a variety of genetic and health data.

Us Research Program to Test Options for Returning Results

The program's participant center at the Scripps Research Translational Institute is planning to test different modules for returning results.

The project has signed up about 170,000 participants so far, of whom 100,000 are fully enrolled, and plans to enhance recruitment through pop-up clinics.

The multi-disciplinary health initiative aims to sequence over 100,000 patients' genomes by 2023 as part of its Mosaic Project.  

For the two five year grants, the NIH will favor applicants with experience providing counseling throughout the US and to diverse and disadvantaged communities.  

The centers will generate genomic data from biosamples contributed by participants in the program and analyze data that will be returned to them.

Eric Green, NHGRI director

Fifteen years after the Human Genome Project was declared completed, genomic medicine is beginning to be implemented, sooner than Green and others had expected.

Pages

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.